MedPath

ITALFARMACO SA

🇪🇸Spain
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.italfarmaco.es

Clinical Trials

2

Active:1
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 3:1

Drug Approvals

1

SFDA:1

Drug Approvals

Pafinur

Approval Date
Jul 18, 2025
SFDA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 3
1 (50.0%)

Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

Phase 3
Completed
Conditions
Vaginal Atrophy
Interventions
Other: Placebo
First Posted Date
2020-10-05
Last Posted Date
2020-12-11
Lead Sponsor
Italfarmaco S.A
Target Recruit Count
167
Registration Number
NCT04574999
Locations
🇪🇸

Hospital Sierrallana, Torrelavega, Cantabria, Spain

🇪🇸

Hospital Ruber Internacional, Madrid, Castiglia, Spain

🇪🇸

Centre Mèdic Teknon S.L., Barcelona, Catalogna, Spain

and more 9 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.